Exceptional Disease Courses After the Use of CAM: Selection, Registration, Medical Assessment, and Research. An International Perspective
Authors:
- 1 September 2006
- journal article
- research article
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 12 (7) , 607-613
Abstract
Objectives: To describe the different approaches that investigators in several countries have used to obtain, register, assess, and research exceptional case histories after the use of complementary and alternative medicine (CAM). Methods: Searches have been carried out currently in the databases PubMed and MEDLINE® using the keywords: exceptional disease course/best and worst cases/best-case series + use of CAM. We have only found a few papers limited to best-case series and cancer. Furthermore, we have used the "snowball method" by contacting researchers in different countries starting with with the National Cancer Institute in the United States in order to get information about ongoing approaches to obtain, register, assess, and research exceptional case histories after the use of CAM. Results: There appears to be a gap between "evidence-based" knowledge drawn from randomized controlled trials, systematic reviews, and meta-analyses and experience-based knowledge of treatment outcomes reported by patients and CAM providers. Several research groups in different countries have initiated studies on patients experiencing exceptional treatment outcomes after the use of CAM. Four different approaches to collecting and assessing such case histories have been identified. Three of the approaches collect histories from the treatment providers, whereas the fourth recruits case histories mainly from patients themselves. The medical assessments are generally similar, and seek to document whether the course of disease is different than would have been expected in a conventional treatment situation. Conclusions: Given differences in the current procedures, the establishment of an international formal collaboration for the recruitment, assessment, and study of exceptional patients is likely to take time. Comparative studies may, however, generate new knowledge about exceptional disease courses across disease categories, cultural contexts, and national boundaries. Our recommendations are that therapeutic approaches that show promising results should warrant prospective study and randomized clinical trials. In addition we recommend that there be (1) agreement on the definition of an exceptional patient, (2) agreement on the interpretation of treatment results, (3) agreement on content requirements of medical records, (4) more consideration of worst cases, (5) more international exchange of experience with registration procedures, and (6) more international exchange of experience with medical assessment procedures.Keywords
This publication has 12 references indexed in Scilit:
- An exploratory retrospective study of people suffering from hypersensitivity illnesses who attend medical or classical homeopathic treatmentHomeopathy, 2006
- Homeopathic medical practice: Long-term results of a cohort study with 3981 patientsBMC Public Health, 2005
- Use of complementary and alternative medicine in the scandinavian countriesScandinavian Journal of Primary Health Care, 2005
- Patients’ assessments of the effectiveness of homeopathic care in Norway: A prospective observational multicentre outcome studyHomeopathy, 2005
- Translational Research in Cancer Complementary and Alternative Medicine: The National Cancer Institute's Best Case Series ProgramClinical Journal of Oncology Nursing, 2004
- Measuring the effects of acupuncture and homoeopathy in general practice: An uncontrolled prospective documentation approachBMC Public Health, 2004
- A survey of acupuncture patients: results from a questionnaire among a random sample in the general population in NorwayComplementary Therapies in Medicine, 2000
- Trends in Alternative Medicine Use in the United States, 1990-1997JAMA, 1998
- Unconventional Medicine in the United States -- Prevalence, Costs, and Patterns of UseNew England Journal of Medicine, 1993
- National Cancer Institute's Evaluation of Unconventional Cancer TreatmentsJNCI: Journal of the National Cancer Institute, 1992